Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation

Elevated levels of erythropoietin (EPO) are associated with an increased risk of death in renal transplant recipients (RTRs), but the underlying mechanisms remain unclear. Emerging data suggest that EPO stimulates production of the phosphaturic hormone fibroblast growth factor 23 (FGF23), another st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Med
Autores principales: Eisenga, Michele F., De Jong, Maarten A., Leaf, David E., Nolte, Ilja M., De Borst, Martin H., Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7356141/
https://ncbi.nlm.nih.gov/pubmed/32512806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9061737
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares